Ligand Portfolio

We believe Ligand has assembled one of the largest portfolio of assets among its biotech peers with over 100 fully funded partnered programs.

The portfolio covers a diverse array of indications with many programs in late stages of development.

We believe Ligand has assembled one of the largest portfolio of assets among its biotech peers with over 100 fully funded partnered programs.

The portfolio covers a diverse array of indications with many programs in late stages of development.



Pie Chart


Pie Chart
Distribution of Therapeutic Areas
Oncology37%
CNS10%
Inflammation16%
Metabolic Disease10%
Blood Disorder8%
Anti-microbial3%
Anti-viral4%
Cardiology4%
Other8%


Distribution of Therapeutic Areas

Pie Chart
Distribution of Partners
GSK8
Viking Therapeutics5
Merck4
Pfizer4
BMS4
AstraZeneca4
Eli Lilly4
Avion Pharmaceuticals4
CURx Pharmaceuticals2
Sanofi Aventis2



 

 



Distribution of Clinical Stage

Pie Chart

Distribution of Partner Type
Pie Chart

Site 'Main' Navigation: